<DOC>
	<DOCNO>NCT02042924</DOCNO>
	<brief_summary>This pilot sub-study patient receive myeloablative transplant use total body irradiation ( TBI ) total marrow irradiation ( TMI ) preparative regimen . The objective stub-study estimate heterogeneity cellular proliferation ( FLT-PET uptake ) well heterogeneity marrow composition distribution ( measure use whole body water-fat MRI ) use positron emission tomography imaging . This used design future trial well determine feasibility PET MRI imaging .</brief_summary>
	<brief_title>Pilot Study Multi-Modality Imaging Patients With Hematologic Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Diagnosis hematologic malignancy fit one follow category : Newly diagnose and/or day 14 postinduction chemotherapy Relapsed , include relapse hematopoietic cell transplant Planned hematopoietic cell transplant ( enrol `` close '' ) within 100 day post hematopoietic cell transplant ( enrol posttransplant ) preparative regimen include either total marrow irradiation ( TMI ) total body irradiation ( TBI ) Undergoing natural killer cell therapy ( without subsequent transplant ) Aged 18 year old Not pregnant woman childbearing potential confirmatory pregnancy test prior image per routine procedure Adequate renal function ( estimate glomerular filtration rate &gt; 60 ml/min ) determine serum creatinine level perform part standard care within 7 day image Able willing provide write consent Otherwise eligible patient meet one contraindicate MRI , may enroll study without undergo MRI : ferromagnetic implant history shrapnel shot gun injury large fit magnet ( approximate body mass index â‰¥ 40 ) cardiac pacemaker implant device MRcompatible claustrophobia large tattoo</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Leukemia</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>Myeloma</keyword>
	<keyword>Myelodysplastic Syndrome</keyword>
</DOC>